RSL is commercializing a breakthrough diagnostic sensor technology, called Fiber Optic Surface Plasmon Resonance (FO-SPR), which utilizes fiber optics and antibodies to achieve accurate biomarker identification.
The disposable sensor, in combination with its planned hand-held analyzer will provide significant improvements in size (portability), performance (3x faster), and cost (60% lower), relative to currently available diagnostic instrumentation. RSLM's mission is to provide a unique, breakthrough diagnostic system for point-of-care and in-vivo applications of biomarkers in blood, wound and spinal fluids. Four (4) patents with broad claims are pending on the technology. (Target Launch:2008)